The field of cardiac mechanical assist devices hasachieved a number of striking technical breakthroughsover the past 40 years.1 Emblematic of the type of important technical accomplishments that have been achieved in this field has been the development of the portable, battery-driven left ventricular assist device (LVAD) for patients with intractable cardiac failure. Although LVADs have been used primarily as a “bridge to transplantation, ” a number of centers have now begun to implant LVADs as an alternative to transplantation.2 Indeed, as the technology in this field improves, it is entirely conceivable that LVADs will evolve into small, unobtrusive devices that will run on small, portable, long-lasting battery supplies that will not requ...
In patients with refractory end-stage heart failure, cardiac transplantation remains the only establ...
Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to addit...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...
The increasing number of patients awaiting heart transplant and the shortage of donors led to the de...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
Objective: To study the achievability of device weaning in patients receiving left ventricular assis...
The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in...
AbstractLeft ventricular assist devices are becoming an increasingly prevalent therapy for patients ...
comorbidities, LVADs can be used for durable, indefinite support as a destination therapy (DT). For ...
Despite major advances in the treatment of heart failure over the past two decades, improving the na...
In 1963, Dr Michael DeBakey successfully implanted the first left ventricular assist device. Through...
PURPOSE OF REVIEW Use of durable left ventricular assist devices (LVADs) has increased considerab...
Left ventricular assist devices (LVADs) have been developed to support end-stage heart failure patie...
Background Left ventricular assist devices (LVADs) have been used as an effective therapeutic optio...
In patients with refractory end-stage heart failure, cardiac transplantation remains the only establ...
Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to addit...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...
The increasing number of patients awaiting heart transplant and the shortage of donors led to the de...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
Objective: To study the achievability of device weaning in patients receiving left ventricular assis...
The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in...
AbstractLeft ventricular assist devices are becoming an increasingly prevalent therapy for patients ...
comorbidities, LVADs can be used for durable, indefinite support as a destination therapy (DT). For ...
Despite major advances in the treatment of heart failure over the past two decades, improving the na...
In 1963, Dr Michael DeBakey successfully implanted the first left ventricular assist device. Through...
PURPOSE OF REVIEW Use of durable left ventricular assist devices (LVADs) has increased considerab...
Left ventricular assist devices (LVADs) have been developed to support end-stage heart failure patie...
Background Left ventricular assist devices (LVADs) have been used as an effective therapeutic optio...
In patients with refractory end-stage heart failure, cardiac transplantation remains the only establ...
Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to addit...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...